AROXITIN 20mg Tablet 10s

Frequently asked questions

• Onset of action

  The effect of this medicine is cumulative and may take months to show. It varies depending on the intended use and the dosing.

• Duration of Effect

  The time for which this medicine remains effective in the body is not clearly established. Dosing, duration and the condition for which this medicine is given determine the effective time duration.

• Safe with Alchohol?

  Avoid or limit the uptake of alcohol while using this medicine. It is advised to refrain from driving vehicles and operating heavy machinery while using this medicine.

• Is it habit forming?

  No habit forming tendencies were reported.

• Usage in pregnancy?

  Use of this medicine by pregnant women is not recommended as the risk of adverse effect on the fetus is very high. Consult your doctor if you are pregnant or are planning a pregnancy while taking this medicine.

• Usage while breast-feeding?

  Use of this medicine by breastfeeding women is not recommended unless necessary. If necessary, your doctor may advise you to stop breastfeeding before treatment with this medicine is initiated.

• Monoamine oxidase inhibitors (MAOI)

  This medicine is not recommended for use while a MAOI medicine (Rasagiline/Selegiline/methylene blue etc.) is being consumed. This medicine should be consumed at least 14 days after stopping the use of MAOI medicines.

• Thioridazine

  This medicine is not recommended for use if the patient is taking Thioridazine (medicine used to treat schizophrenia).

• Pimozide

  This medicine is not recommended for use if the patient is taking Pimozide (anti psychotic medicine).

• Allergy

  This medicine is not recommended for use if you a known history of allergy to AROXITIN 20mg Tablet 10s or any other ingredient present with it.

• Pregnancy

  Use of this medicine by pregnant women is not recommended as the risk of adverse effect on the fetus is very high. Consult your doctor if you are pregnant or are planning a pregnancy while taking this medicine.

• Breast-feeding

  Use of this medicine by breastfeeding women is not recommended unless necessary. If necessary, your doctor may advise you to stop breastfeeding before treatment with this medicine is initiated.

• Suicidal thinking and behavior

  Use of this medicine may cause suicidal thought and change the behavior of the user. This risk is increasingly high in young patients. It is recommended to screen the patient for such behavior before starting the treatment. Any change in behavior and thought process after taking this medicine should be reported to the doctor immediately.

• Serotonin syndrome

  Serotonin syndrome

• Neuroleptic malignant syndrome

  Use of this medicine may cause Neuroleptic malignant syndrome characterized by high fever, muscle stiffness, extreme changes in blood pressure, excessive sweating and salivation. The use of this medicine should be stopped as soon as these side effects are experienced.

• Hypertension

  Use of this medicine is associated with a sharp increase in blood pressure levels. It is recommended to control hypertension using appropriate medicines before starting the treatment with AROXITIN 20mg Tablet 10s .

• Bleeding disorders

  Use of this medicine may cause unusual bleeding and bruising and hence should be used with caution in patients suffering from bleeding disorders. Use of medicines that are known to cause gastrointestinal bleeding, (example: aspirin, paracetamol, ibuprofen etc), should be avoided while taking AROXITIN 20mg Tablet 10s .

• Glaucoma

  This medicine should be used with caution in patients suffering from angle closure glaucoma. The symptoms of this disease may worsen upon using AROXITIN 20mg Tablet 10s and hence caution is advised.

• Seizure disorder

  Use of this medicine may cause seizures and hence should be used with caution in patients suffering from epilepsy.

• Manic episodes

  Use of this medicine may cause agitation and aggressive behavior in some patients. The patient should be screened for bipolar disorder before starting the treatment course with this medicine.

• Heart disease

  This medicine should be used with caution in patients suffering from a heart or blood vessel disorder.

• Hyponatremia

  This medicine may decrease the sodium levels in the body and hence should be used with caution in patients taking diuretic medicines.

• Bone fractures

  Use of this medicine has been associated with an increase in the incidence of bone fractures. Report any incidence of bone pain to the doctor while taking AROXITIN 20mg Tablet 10s .

• Drowsiness and cognitive impairment

  Use of this medicine has been associated with drowsiness and impairment of cognition. It is advised to refrain from driving vehicles or operating heavy machinery while taking this medicine.

• Sexual dysfunction

  Use of this medicine may cause sexual dysfunction. These dysfunctions may include a decrease in libido, erectile disorders, or painful orgasm.

• Withdrawal symptoms

  Use of this medicine should not be discontinued abruptly. It is advised to gradually reduce the dose of this medicine.

• Pediatric use

  This medicine is not recommended for use in patients aged below 18 years.

• Use in elderly

  This medicine should be used with caution in elderly patients as the risk of adverse effects is significantly high.

Take AROXITIN 20mg Tablet 10s as instructed by the doctor. Do not use in smaller or larger than the recommended dose. The dose is likely to change over time based on your response and hence adherence to the changes is a must. Do not stop the use of this medicine abruptly.

• practo.com - Paroxetine:20mgParoxetine:20mg [Internet]. Available from: https://www.practo.com/medicine-info/paroxetine-220-api [cited 8 october 2019]. 8 Feb 2018
• dailymed.nlm.nih.gov - Paroxetine:20mg [Internet]. Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=899aee24-bd00-ee0a-669d-f4fbe96ef269 [cited 8 october 2019]. January 11, 2018
• drugbank.ca - Paroxetine:20mg [Internet]. Available from: https://www.drugbank.ca/drugs/DB00715 [cited 8 october 2019]. October 08, 2019